These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Calreticulin transacetylase mediates the acetylation of nitric oxide synthase by polyphenolic acetate. Bansal S; Gaspari M; Raj HG; Kumar A; Cuda G; Verheij E; Tyagi YK; Ponnan P; Rastogi RC; Parmar VS Appl Biochem Biotechnol; 2008 Jan; 144(1):37-45. PubMed ID: 18415985 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective cyclooxygenase-1 (COX-1) inhibitors. Vitale P; Tacconelli S; Perrone MG; Malerba P; Simone L; Scilimati A; Lavecchia A; Dovizio M; Marcantoni E; Bruno A; Patrignani P J Med Chem; 2013 Jun; 56(11):4277-99. PubMed ID: 23651359 [TBL] [Abstract][Full Text] [Related]
11. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation. Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038 [TBL] [Abstract][Full Text] [Related]
12. The role of calreticulin transacetylase in the activation of human platelet nitrite reductase by polyphenolic acetates. Arora S; Tyagi YK; Kumar A; Majumder S; Saluja D; Raj HG; Chatterjee S; Saso L; Prasad AK; Parmar VS Biol Pharm Bull; 2009 Feb; 32(2):161-5. PubMed ID: 19182369 [TBL] [Abstract][Full Text] [Related]
13. Antiplatelet effects of piplartine, an alkamide isolated from Piper tuberculatum: possible involvement of cyclooxygenase blockade and antioxidant activity. Fontenele JB; Leal LK; Silveira ER; Felix FH; Bezerra Felipe CF; Viana GS J Pharm Pharmacol; 2009 Apr; 61(4):511-5. PubMed ID: 19298699 [TBL] [Abstract][Full Text] [Related]
14. Calreticulin transacetylase catalyzed modification of the TNF-alpha mediated pathway in the human peripheral blood mononuclear cells by polyphenolic acetates. Singh U; Kumar A; Sinha R; Manral S; Arora S; Ram S; Mishra RK; Gupta P; Bansal SK; Prasad AK; Biswal S; Parmar VS; Raj HG Chem Biol Interact; 2010 May; 185(3):263-70. PubMed ID: 20188080 [TBL] [Abstract][Full Text] [Related]
15. Antiplatelet effect of a new inhibitor of thromboxane synthase and thromboxane A2 receptors. Tubaro E; Belogi L; Mezzadri CM Arzneimittelforschung; 1996 Jan; 46(1):35-41. PubMed ID: 8821515 [TBL] [Abstract][Full Text] [Related]
16. The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase. Lee JJ; Yu JY; Lee JH; Zhang WY; Kim TJ; Myung CS; Yun YP Arch Pharm Res; 2010 Mar; 33(3):387-94. PubMed ID: 20361303 [TBL] [Abstract][Full Text] [Related]
17. The antiplatelet effects of a new nitroderivative of acetylsalicylic acid--an in vitro study of inhibition on the early phase of platelet activation and on TXA2 production. Lechi C; Andrioli G; Gaino S; Tommasoli R; Zuliani V; Ortolani R; Degan M; Benoni G; Bellavite P; Lechi A; Minuz P Thromb Haemost; 1996 Nov; 76(5):791-8. PubMed ID: 8950792 [TBL] [Abstract][Full Text] [Related]
18. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Schrör K Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, antiproliferative, and antiplatelet activities of oxime- and amide-containing quinolin-2(1H)-one derivatives. Chen IL; Chang KM; Miaw CL; Liao CH; Chen JJ; Wang TC Bioorg Med Chem; 2007 Oct; 15(20):6527-34. PubMed ID: 17689252 [TBL] [Abstract][Full Text] [Related]
20. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation. Vezza R; Nenci GG; Gresele P J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]